What New Prior Authorization Metrics Mean for Clinical Labs
KFF looks into payer claims denials, which continue to be scrutinized
KFF looks into payer claims denials, which continue to be scrutinized
From – National Intelligence Report
After much lobbying, debate and delay, the Centers for Medicare & Medicaid Services (CMS) final rule implementing the Protecting Access to Medicare Act (PAMA) changes to the Clinical Laboratory Fee Schedule (CLFS) was released…
From – National Intelligence Report
While Big Data can mean new opportunities for increasing efficiencies and revenues for the laboratory industry, the Centers for Medicare & Medicaid Services (CMS) claims Big Data has yielded big savings for…
From – National Intelligence Report
The U.S. Department of Health and Human Services (HHS), in collaboration with AARP, is challenging health care organizations to design a…
From – National Intelligence Report
In January, the Centers for Medicare & Medicaid Services (CMS) Acting Administrator Andy Slavitt indicated the “Meaningful Use program as it has existed, will now…